Chandan Healthcare Ltd Faces Bearish Momentum Amid Technical Downturn

Price Movement and Market Context

On 18 June 2026, Chandan Healthcare Ltd closed at ₹212.60, down 5.53% from the previous close of ₹225.05. The intraday range was between ₹206.00 and ₹219.00, indicating heightened volatility. The stock remains significantly below its 52-week high of ₹358.00, while still above the 52-week low of ₹184.50. This wide price band underscores the stock’s recent struggles amid a challenging market environment.

Comparatively, the Sensex has shown resilience, with a 1-week return of +3.75% and a 1-month return of +1.87%, whereas Chandan Healthcare has declined by 7.02% and 13.87% over the same periods respectively. Year-to-date, the stock has plunged 34.49%, far underperforming the Sensex’s modest 7.82% decline. This divergence highlights sector-specific or company-specific headwinds impacting the stock.

Technical Indicators Signal Bearish Momentum

The technical landscape for Chandan Healthcare has deteriorated, with several key indicators pointing towards sustained bearishness. The Moving Average Convergence Divergence (MACD) on the weekly chart remains firmly bearish, reflecting downward momentum in price trends. Although the monthly MACD data is unavailable, the weekly signal alone suggests persistent selling pressure.

The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no clear signal, hovering in neutral territory. This indicates that while the stock is not yet oversold, it lacks the momentum to trigger a bullish reversal in the near term.

Bollinger Bands on the weekly chart also confirm bearishness, with the price trending near the lower band, signalling increased volatility and potential continuation of the downtrend. Daily moving averages reinforce this view, as the stock price remains below key averages, confirming a bearish short-term trend.

Mixed Signals from Other Technical Tools

The Know Sure Thing (KST) indicator on the weekly timeframe offers a mildly bullish signal, suggesting some underlying positive momentum that could provide limited support. However, this is overshadowed by the Dow Theory’s weekly and monthly mildly bearish stance, which emphasises the predominance of downward trends in the stock’s price action.

On-Balance Volume (OBV) readings on both weekly and monthly charts are mildly bearish, indicating that volume trends are not supporting a price recovery. This volume-price divergence often precedes further declines, as selling pressure outweighs buying interest.

Mojo Score and Market Capitalisation

Chandan Healthcare holds a Mojo Score of 40.0, categorised as a Sell rating, reflecting weak technical and fundamental parameters. This is the company’s first formal rating, marking a cautious stance by analysts. The micro-cap status further emphasises the stock’s limited liquidity and higher risk profile, which may deter institutional investors.

The downgrade to a Sell grade is consistent with the technical trend change from mildly bearish to outright bearish, signalling a deteriorating outlook. Investors should note that the stock’s technical and fundamental metrics currently do not favour accumulation.

Longer-Term Performance and Sector Comparison

While the stock has marginally gained 0.62% over the past year, it still lags the Sensex’s 3.09% decline, indicating relative underperformance. Over longer horizons, the Sensex has delivered robust returns of 27.94% over three years and 53.50% over five years, underscoring the stock’s failure to keep pace with broader market growth.

Within the hospital sector, Chandan Healthcare’s technical weakness contrasts with some peers that have shown resilience or recovery, suggesting company-specific challenges. The sector’s overall health remains mixed, with selective opportunities but also pockets of stress.

Investor Implications and Outlook

Given the current technical signals, investors should exercise caution with Chandan Healthcare Ltd. The bearish MACD, daily moving averages, and Bollinger Bands indicate that the stock may continue to face downward pressure in the near term. The absence of strong RSI signals suggests no imminent reversal, while volume trends do not support a rally.

For risk-averse investors, the micro-cap status combined with weak technicals and a Sell Mojo Grade advises against initiating new positions. Those holding the stock may consider tightening stop-loss levels or evaluating exit strategies to mitigate downside risk.

Conclusion

Chandan Healthcare Ltd’s recent technical deterioration and negative price momentum reflect a challenging phase for the stock. The combination of bearish MACD, daily moving averages, and Bollinger Bands, alongside a Sell Mojo Grade, signals caution for investors. While some mildly bullish signals from KST offer limited hope, the overall technical and volume trends suggest further downside risk.

Investors should monitor the stock closely for any signs of technical recovery or fundamental improvement before considering new exposure. Meanwhile, exploring alternative hospital sector stocks with stronger momentum and fundamentals may prove prudent in the current market environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →